Strategic Advocates LLC Sells 1,337 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Strategic Advocates LLC cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 7,793 shares of the medical equipment provider’s stock after selling 1,337 shares during the period. Intuitive Surgical makes up about 1.4% of Strategic Advocates LLC’s holdings, making the stock its 17th largest holding. Strategic Advocates LLC’s holdings in Intuitive Surgical were worth $4,068,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $558,807,000. International Assets Investment Management LLC raised its stake in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. FMR LLC lifted its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB grew its stake in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares in the last quarter. Finally, State Street Corp increased its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 28,843 shares of company stock worth $15,357,560 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 1.3 %

Intuitive Surgical stock opened at $580.18 on Friday. The firm has a market cap of $206.65 billion, a price-to-earnings ratio of 90.51, a PEG ratio of 5.52 and a beta of 1.39. The stock has a fifty day simple moving average of $549.32 and a two-hundred day simple moving average of $507.50. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ISRG shares. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday. CICC Research began coverage on Intuitive Surgical in a research report on Monday. They issued a “neutral” rating and a $550.00 price objective for the company. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Mizuho lifted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.